Observational studyViruses2023

Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting.

Yoshikazu Mutoh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.